Centessa Pharmaceuticals PLC ADR (CNTA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $26.77
• Market Cap: $3.94B
• EPS: $-1.89
• 52-Week High: $30.58
• 52-Week Low: $9.60

Market Sentiment

Centessa Pharmaceuticals PLC ADR currently has a Neutral sentiment score of 0.08.

About Centessa Pharmaceuticals PLC ADR

Centessa Pharmaceuticals PLC is a forward-looking biotechnology company headquartered in Cambridge, UK, dedicated to revolutionizing the therapeutic landscape through its distinct drug discovery and development platform. With a robust pipeline that encompasses multiple therapeutic areas, including oncology and rare diseases, Centessa aims to meet critical unmet medical needs by advancing innovative therapies. The company's strategic integration of cutting-edge scientific research and thorough...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Centessa Pharmaceuticals PLC ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CNTA pay dividends?

Centessa Pharmaceuticals PLC ADR (CNTA) does not currently pay a regular dividend.

What is CNTA's market cap?

Centessa Pharmaceuticals PLC ADR (CNTA) has a market capitalization of $3.94B with a current stock price of $26.77.